Skip to main content

ARAY

Stock
Health Care
Medical Devices

Performance overview

ARAY Price
Price Chart

Forward-looking statistics

Beta
2.11
Risk
80.07%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

accuray incorporated (nasdaq: aray) is a radiation oncology company that develops, manufactures and sells precise, innovative tumor treatment solutions that set the standard of care with the aim of helping patients live longer, better lives. the company's leading-edge technologies deliver the full range of radiation therapy and radiosurgery treatments. for more information, please visit www.accuray.com. for career opportunities, please visit http://www.accuray.com/careers.

Company info

SectorHealth Care
IndustryMedical Devices
Employees1K
Market cap$176.7M

Fundamentals

Enterprise value$224.2M
Revenue$465.3M
Revenue per employee—
Profit margin0.14%
Debt to equity289.67

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)-$0.16
Dividend per share—
Revenue per share$4.61
Avg trading volume (30 day)$1M
Avg trading volume (10 day)$1M
Put-call ratio—

Macro factor sensitivity

Growth+6.5
Credit+1.0
Liquidity-2.6
Inflation+2.0
Commodities+1.4
Interest Rates-2.5

Valuation

Dividend yield0.00%
PEG Ratio11.83
Price to sales0.31
P/E Ratio11.83
Enterprise Value to Revenue0.48
Price to book2.95

Upcoming events

Next earnings dayMay 1, 2025
Next dividend day—
Ex. dividend day—

News

Here's Why You Should Hold Accuray Stock in Your Portfolio for Now

ARAY continues to witness strength in its flagship, CyberKnife system, along with robust global performance.

Zacks Investment Research (June 18, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free